186 related articles for article (PubMed ID: 21482111)
21. Ultrastructural study of the motor end-plate in botulism and Lambert-Eaton myasthenic syndrome.
Tsujihata M; Kinoshita I; Mori M; Mori K; Shirabe S; Satoh A; Nagataki S
J Neurol Sci; 1987 Nov; 81(2-3):197-213. PubMed ID: 3694228
[TBL] [Abstract][Full Text] [Related]
22. Clinical neurophysiology of neuromuscular junction disease.
Juel VC
Handb Clin Neurol; 2019; 161():291-303. PubMed ID: 31307607
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
Engel AG; Lindstrom JM; Lambert EH; Lennon VA
Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
[TBL] [Abstract][Full Text] [Related]
24. A novel dynamin-2 gene mutation associated with a late-onset centronuclear myopathy with necklace fibres.
Casar-Borota O; Jacobsson J; Libelius R; Oldfors CH; Malfatti E; Romero NB; Oldfors A
Neuromuscul Disord; 2015 Apr; 25(4):345-8. PubMed ID: 25633151
[TBL] [Abstract][Full Text] [Related]
25. Abnormal neuromuscular transmission in an infantile myasthenic syndrome.
Albers JW; Faulkner JA; Dorovini-Zis K; Barald KF; Must RE; Ball RD
Ann Neurol; 1984 Jul; 16(1):28-34. PubMed ID: 6087719
[TBL] [Abstract][Full Text] [Related]
26. [Neurophysiologic assessment of disorders affecting the neuromuscular junction].
Kuwabara S
Brain Nerve; 2011 Jul; 63(7):713-7. PubMed ID: 21747141
[TBL] [Abstract][Full Text] [Related]
27. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
[TBL] [Abstract][Full Text] [Related]
28. Novel congenital myasthenic syndromes associated with defects in quantal release.
Milone M; Fukuda T; Shen XM; Tsujino A; Brengman J; Engel AG
Neurology; 2006 Apr; 66(8):1223-9. PubMed ID: 16525123
[TBL] [Abstract][Full Text] [Related]
29. The Safety Factor for Neuromuscular Transmission: Effects of Dimethylsulphoxide, Cannabinoids and Synaptic Homeostasis.
Odierna GL; Phillips WD
J Neuromuscul Dis; 2021; 8(5):831-844. PubMed ID: 34334412
[TBL] [Abstract][Full Text] [Related]
30. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
Niks EH; Kuks JB; Wokke JH; Veldman H; Bakker E; Verschuuren JJ; Plomp JJ
Muscle Nerve; 2010 Aug; 42(2):283-8. PubMed ID: 20544919
[TBL] [Abstract][Full Text] [Related]
31. A homozygous mutation in GMPPB leads to centronuclear myopathy with combined pre- and postsynaptic defects of neuromuscular transmission.
Nicolau S; Liewluck T; Shen XM; Selcen D; Engel AG; Milone M
Neuromuscul Disord; 2019 Aug; 29(8):614-617. PubMed ID: 31378432
[TBL] [Abstract][Full Text] [Related]
32. Monozygous twins with neuromuscular transmission defects at opposite sides of the motor endplate.
Punga AR; Nygren I; Askmark H; Stålberg EV
Acta Neurol Scand; 2009 Mar; 119(3):207-11. PubMed ID: 18684214
[TBL] [Abstract][Full Text] [Related]
33. Congenital endplate acetylcholinesterase deficiency.
Hutchinson DO; Walls TJ; Nakano S; Camp S; Taylor P; Harper CM; Groover RV; Peterson HA; Jamieson DG; Engel AG
Brain; 1993 Jun; 116 ( Pt 3)():633-53. PubMed ID: 8390325
[TBL] [Abstract][Full Text] [Related]
34. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors.
Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD
Exp Neurol; 2012 Oct; 237(2):286-95. PubMed ID: 22789393
[TBL] [Abstract][Full Text] [Related]
35. Arthrogryposis multiplex congenita due to congenital myasthenic syndrome.
Vajsar J; Sloane A; MacGregor DL; Ronen GM; Becker LE; Jay V
Pediatr Neurol; 1995 Apr; 12(3):237-41. PubMed ID: 7619191
[TBL] [Abstract][Full Text] [Related]
36. Adult centronuclear myopathies: A hospital-based study.
Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
[TBL] [Abstract][Full Text] [Related]
37. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations.
Ohno K; Quiram PA; Milone M; Wang HL; Harper MC; Pruitt JN; Brengman JM; Pao L; Fischbeck KH; Crawford TO; Sine SM; Engel AG
Hum Mol Genet; 1997 May; 6(5):753-66. PubMed ID: 9158150
[TBL] [Abstract][Full Text] [Related]
38. Inflammation at the neuromuscular junction in myasthenia gravis.
Maselli RA; Richman DP; Wollmann RL
Neurology; 1991 Sep; 41(9):1497-504. PubMed ID: 1891103
[TBL] [Abstract][Full Text] [Related]
39. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
[TBL] [Abstract][Full Text] [Related]
40. An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.
Albuquerque EX; Rash JE; Mayer RF; Satterfield JR
Exp Neurol; 1976 Jun; 51(3):536-63. PubMed ID: 179836
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
